• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NYSE Content Update: Two MSCI Indexes to Begin Trading on NYSE Arca Options

    2/25/26 8:55:00 AM ET
    $BMY
    $DT
    $ICE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $BMY alert in real time by email

    NYSE issues a pre-market daily advisory direct from the trading floor.

    NEW YORK, Feb. 25, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

    Ashley Mastronardi delivers the pre-market update on February 25th

    • Equities are higher Wednesday morning as Nvidia prepares to release its fourth quarter earnings after market close.
    • MSCI Emerging Markets Index Options and MSCI EAFE Index Options are set to begin trading on NYSE Arca Options today under the ticker symbols MXEF and MXEA
    • Dynatrace (NYSE:DT) CEO Rick McConnell will join NYSE Live today to announce the recent milestone of surpassing $1 billion in lifetime AWS Sales.
    • AI-enabled design leader Canva announced the acquisition of MangoAI and Cavalry to expand its professional creative suite and AI capabilities.

    Opening Bell

    Americares highlights the importance of increasing access to healthcare

    Closing Bell

    Bristol-Myers Squibb (NYSE:BMY) marks its annual meeting of top 100 global leaders

    For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com

    Covista CEO joined Taking Stock on February 24.

    NYSE Logo (PRNewsfoto/New York Stock Exchange)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-update-two-msci-indexes-to-begin-trading-on-nyse-arca-options-302697102.html

    SOURCE New York Stock Exchange

    Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2026/25/c4980.html

    Get the next $BMY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BMY
    $DT
    $ICE

    CompanyDatePrice TargetRatingAnalyst
    Dynatrace Inc.
    $DT
    6/16/2026$60.00Buy
    UBS
    Dynatrace Inc.
    $DT
    6/16/2026$43.00 → $50.00Outperform
    BMO Capital Markets
    Dynatrace Inc.
    $DT
    5/21/2026Outperform
    William Blair
    Dynatrace Inc.
    $DT
    5/14/2026$45.00 → $43.00Outperform
    BMO Capital Markets
    Dynatrace Inc.
    $DT
    5/13/2026Buy → Neutral
    Guggenheim
    Dynatrace Inc.
    $DT
    4/23/2026$40.00Neutral
    Rothschild & Co Redburn
    Dynatrace Inc.
    $DT
    4/21/2026$45.00Buy
    Goldman
    Intercontinental Exchange Inc.
    $ICE
    4/8/2026$190.00Outperform
    Keefe Bruyette
    More analyst ratings

    $BMY
    $DT
    $ICE
    SEC Filings

    View All

    SEC Form DEFA14A filed by Dynatrace Inc.

    DEFA14A - Dynatrace, Inc. (0001773383) (Filer)

    7/10/26 6:42:44 AM ET
    $DT
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEF 14A filed by Dynatrace Inc.

    DEF 14A - Dynatrace, Inc. (0001773383) (Filer)

    7/10/26 6:41:16 AM ET
    $DT
    Computer Software: Prepackaged Software
    Technology

    Dynatrace Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Dynatrace, Inc. (0001773383) (Filer)

    7/1/26 6:33:08 AM ET
    $DT
    Computer Software: Prepackaged Software
    Technology

    $BMY
    $DT
    $ICE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 14, 2024 - FDA Roundup: June 14, 2024

    For Immediate Release: June 14, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Rule. The proposal would exempt Grade “A” cottage cheese that appears on the Interstate Milk Shippers List from the requirements of the r

    6/14/24 3:54:45 PM ET
    $MMSI
    $BMY
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    March 8, 2024 - FDA Roundup: March 8, 2024

    For Immediate Release: March 08, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced proposed new regulations to provide animal drug sponsors with predictable requirements for the labeling of prescription and over-the-counter new animal drugs, as well as new animal drugs for use in animal feeds. The proposed content and

    3/8/24 3:26:46 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMY
    $DT
    $ICE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Customer Officer Mcmahon Stephen A bought $107,250 worth of shares (3,000 units at $35.75), increasing direct ownership by 661% to 3,454 units (SEC Form 4)

    4 - Dynatrace, Inc. (0001773383) (Issuer)

    3/4/26 6:33:46 PM ET
    $DT
    Computer Software: Prepackaged Software
    Technology

    EVP,Chief Med.Offr.,Drug Dev. Hirawat Samit bought $202,215 worth of shares (4,250 units at $47.58), increasing direct ownership by 5% to 83,513 units (SEC Form 4)

    4 - BRISTOL MYERS SQUIBB CO (0000014272) (Issuer)

    4/29/25 6:14:13 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Boerner Christopher S. bought $110,096 worth of shares (2,000 units at $55.05), increasing direct ownership by 2% to 104,626 units (SEC Form 4)

    4 - BRISTOL MYERS SQUIBB CO (0000014272) (Issuer)

    2/21/25 7:09:34 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMY
    $DT
    $ICE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on Dynatrace with a new price target

    UBS resumed coverage of Dynatrace with a rating of Buy and set a new price target of $60.00

    6/16/26 8:12:50 AM ET
    $DT
    Computer Software: Prepackaged Software
    Technology

    BMO Capital Markets reiterated coverage on Dynatrace with a new price target

    BMO Capital Markets reiterated coverage of Dynatrace with a rating of Outperform and set a new price target of $50.00 from $43.00 previously

    6/16/26 7:47:04 AM ET
    $DT
    Computer Software: Prepackaged Software
    Technology

    William Blair resumed coverage on Dynatrace

    William Blair resumed coverage of Dynatrace with a rating of Outperform

    5/21/26 8:07:27 AM ET
    $DT
    Computer Software: Prepackaged Software
    Technology

    $BMY
    $DT
    $ICE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NYSE Content Update: Entry Deadline Nears for The Money Awards 2026

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, July 20, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on July 20thThe major averages will look to bounce back as investors navigate a busy week of earnings and new developments in the Middle East.Money20/20's VP of Awards, Granita Chesterson, will join NYSE Live to set the scene for the Money Awards 2026.Entry deadline is July 28, with winners to be announced on October 18.Event re

    7/20/26 9:06:00 AM ET
    $ICE
    $BMO
    Investment Bankers/Brokers/Service
    Finance
    Commercial Banks

    Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

    Expanded collaboration gives BMS the most advanced and most energy-efficient NVIDIA infrastructure in life sciences BMS will deploy NVIDIA DGX Vera Rubin NVL72 systems to scale proprietary AI models, compress discovery timelines, and advance its vision of collaborative hybrid intelligence, where AI scientists work alongside researchers to pursue first- and best-in-class medicines Bristol Myers Squibb (NYSE:BMY, "BMS")), a global biopharmaceutical leader, today announced it will expand its compute infrastructure to deploy an NVIDIA DGX SuperPOD with DGX Vera Rubin NVL72 systems, giving BMS the most powerful and energy-efficient single-owned NVIDIA infrastructure in life sciences. The e

    7/20/26 6:59:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NYSE Content Update: AdvanCell Raises $315 Million to Fight Prostate Cancer

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, July 17, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on July 17thEquities are lower as investors parse through fresh earnings and monitor new activity in the Middle East.NYSE Live will provide exclusive access to Standard Nuclear's executive remarks.CEO Kurt Terrani will also join the program to explain why now was the perfect time to take the energy company public.Shares of STDN

    7/17/26 8:55:00 AM ET
    $ICE
    $UWMC
    Investment Bankers/Brokers/Service
    Finance
    Finance: Consumer Services

    $BMY
    $DT
    $ICE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, NYSE Group Martin Lynn C exercised 15,882 shares at a strike of $57.31 and sold $2,241,713 worth of shares (15,882 units at $141.15) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    7/20/26 4:30:02 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    SVP, Chief Accounting Officer Yates Daniel S. converted options into 1,323 shares and covered exercise/tax liability with 389 shares, increasing direct ownership by 3% to 35,457 units (SEC Form 4) (tax withholding)

    4 - Dynatrace, Inc. (0001773383) (Issuer)

    7/17/26 4:57:49 PM ET
    $DT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form 4 filed by EVP, Chief Revenue Officer Zugelder Dan

    4/A - Dynatrace, Inc. (0001773383) (Issuer)

    7/7/26 4:34:28 PM ET
    $DT
    Computer Software: Prepackaged Software
    Technology

    $BMY
    $DT
    $ICE
    Financials

    Live finance-specific insights

    View All

    NYSE Content Update: Easterly Launches Easterly Snow All Cap Value Fund

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, June 29, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Pete Asch delivers the pre-market update on June 29thInvestors track new developments in the Middle East after the U.S. and Iran agreed to halt hostilities over the weekend.The city of Orlando, Florida says it's seeing more companies establish headquarters or expand business operations in the city.Mayor Buddy Dyer joins NYSE Live to discuss factors behind Orlando's transition

    6/29/26 8:55:00 AM ET
    $ICE
    $DB
    Investment Bankers/Brokers/Service
    Finance
    Major Banks

    Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026

    Bristol Myers Squibb (NYSE:BMY) will announce results for the second quarter of 2026 on Thursday, July 30, 2026. Company executives will review financial results with the investment community during a conference call beginning at 8:15 a.m. ET. Investors and the general public are invited to listen to a live audio webcast of the call at http://investor.bms.com. Materials related to the call will be available on the company's Investor Relations website prior to the start of the conference call. A replay of the webcast will be available here approximately three hours after the conference call concludes. About Bristol Myers Squibb: Transforming Patients' Lives Through Science At Bristol M

    6/18/26 6:59:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bristol Myers Squibb Announces Dividend

    Bristol Myers Squibb (NYSE:BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-three cents ($0.63) per share on the $0.10 par value common stock of the company. The dividend is payable on August 3, 2026, to stockholders of record at the close of business on July 2, 2026. About Bristol Myers Squibb: Transforming Patients' Lives Through Science At Bristol Myers Squibb, our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information about Bristol Myers Squibb, visit

    6/17/26 4:16:00 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMY
    $DT
    $ICE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Dynatrace Inc.

    SC 13G/A - Dynatrace, Inc. (0001773383) (Subject)

    11/14/24 1:22:39 PM ET
    $DT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Dynatrace Inc.

    SC 13G/A - Dynatrace, Inc. (0001773383) (Subject)

    11/12/24 2:24:13 PM ET
    $DT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Dynatrace Inc.

    SC 13G/A - Dynatrace, Inc. (0001773383) (Subject)

    11/12/24 9:55:15 AM ET
    $DT
    Computer Software: Prepackaged Software
    Technology

    $BMY
    $DT
    $ICE
    Leadership Updates

    Live Leadership Updates

    View All

    NIRI Chicago Elects 2026-2027 Officers and Directors

    The Chicago chapter of NIRI, The Association for Investor Relations (NIRI Chicago), has elected 10 officers and directors to its board for the 2026-2027 term, effective July 1. "As capital markets evolve, shareholder expectations continue to rise, and technological advancements reshape how companies engage with investors, the role of the investor relations officer continues to expand in scope and strategic importance," said Brooks O. Rennie, incoming chapter president. "NIRI Chicago is fortunate to be guided by an exceptional board of directors whose leadership, experience and commitment position our organization to remain a leading resource for investor relations professionals across the

    7/7/26 10:42:00 AM ET
    $BY
    $CF
    $TAP
    Major Banks
    Finance
    Agricultural Chemicals
    Industrials

    Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

    WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Felecia W. Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer (CLO). She will oversee Ardelyx's legal, compliance, regulatory, and government affairs operations. Ms. Ettenberg succeeds Elizabeth Grammer, who has chosen to retire after an extraordinary 16-year career at the company. "I am thrilled to welcome Felecia as our new Chief Legal Officer," said Mik

    4/20/26 8:00:00 AM ET
    $ARDX
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dynatrace to Acquire Bindplane to Establish Telemetry Pipelines for AI and Cloud‑Native Observability

    Combined platform will deliver an open-standards-based telemetry pipeline for logs, metrics, and traces, providing control from the edge through analytics Dynatrace (NYSE:DT), the leading AI-powered observability platform, today announced it has signed a definitive agreement to acquire Bindplane, a company whose open-standards-based telemetry pipeline helps organizations capture and manage data at scale. As cloud‑native architectures and AI‑driven development accelerate, organizations are seeing rapid growth in telemetry – the operational signals that show what's happening inside digital systems. Telemetry pipelines that capture, optimize, and deliver this data in an actionable form hav

    4/8/26 4:05:00 PM ET
    $DT
    Computer Software: Prepackaged Software
    Technology